Credit Suisse Ag Gossamer Bio, Inc. Transaction History

Credit Suisse Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.74 - $12.87 $821 - $6,074	-472 Reduced 1.33%	34,903 $75,000
Q3 2022 Nov 10, 2022	BUY	$7.21 - $14.88 $2,213 - $4,568	307 Added 0.88%	35,375 $423,000
Q2 2022 Aug 12, 2022	SELL	$5.97 - $9.97 $19,020 - $31,764	-3,186 Reduced 8.33%	35,068 $293,000
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $13,664 - $20,221	-1,619 Reduced 4.06%	38,254 $332,000
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $58,878 - $81,859	5,818 Added 17.08%	39,873 $451,000
Q3 2021 Nov 12, 2021	BUY	$7.25 - $13.23 $6,989 - $12,753	964 Added 2.91%	34,055 $428,000
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $57,864 - $70,521	-7,233 Reduced 17.94%	33,091 $268,000
Q1 2021 May 14, 2021	SELL	$8.63 - $10.94 $441,571 - $559,766	-51,167 Reduced 55.93%	40,324 $373,000
Q4 2020 Feb 12, 2021	BUY	$8.3 - $13.59 $53,734 - $87,981	6,474 Added 7.61%	91,491 $884,000
Q3 2020 Nov 13, 2020	BUY	$11.3 - $14.75 $24,385 - $31,830	2,158 Added 2.6%	85,017 $1.06 Million
Q2 2020 Aug 12, 2020	BUY	$9.52 - $15.98 $409,293 - $687,028	42,993 Added 107.84%	82,859 $1.08 Million
Q1 2020 May 13, 2020	SELL	$8.0 - $15.48 $65,112 - $125,991	-8,139 Reduced 16.95%	39,866 $404,000
Q4 2019 Feb 12, 2020	BUY	$14.82 - $26.79 $466,059 - $842,491	31,448 Added 189.94%	48,005 $750,000
Q3 2019 Nov 12, 2019	BUY	$16.02 - $22.47 $80,260 - $112,574	5,010 Added 43.39%	16,557 $277,000
Q2 2019 Aug 14, 2019	BUY	$16.12 - $22.89 $186,137 - $264,310	11,547 New	11,547 $256,000

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $83.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.